title: How the Narrative Around J&J Is Shifting After Recent Results and Analyst Upgrades
source: Yahoo
date: 2025-10-22
url: https://finnhub.io/api/news?id=7b5fbe0dfa0343e69c9aa06c708693fc4511e93f913c972e2796cce0e4f564e3
Johnson & Johnson stock has moved back into focus as analysts raise their consensus price target from $185.13 to $198.03. This reflects greater confidence following positive company developments. The upgraded target follows robust quarterly results and optimistic revised guidance, suggesting renewed momentum for the healthcare giant. Stay tuned to discover how you can follow these evolving perspectives and stay ahead of shifts in Johnson & Johnsonâ€™s investment narrative. What Wall Street Has...
